上海药明生物技术有限公司 WuXi Biologics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility 2026-06-05 10:45
WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year 2026-06-03 10:35
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities 2026-05-27 17:14
WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization 2026-05-20 13:44
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index 2026-05-13 11:33
WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access 2026-04-29 20:30
WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival 2026-04-24 19:03
WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics 2026-04-23 14:14
WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing 2026-04-15 10:39
WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year 2026-03-30 13:33
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture 2026-03-25 18:22
WuXi Biologics Reports Record 2025 Annual Results 2026-03-24 19:44
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target 2026-03-22 09:30
WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation 2026-03-13 11:09
WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year 2026-03-02 11:21
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager 2026-02-03 11:22
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody 2026-01-29 10:39
WuXi Biologics and HanchorBio Enter Strategic Partnership to Advance Next-Generation Bi- and Multi-Functional Fusion Protein Pipeline 2026-01-26 17:35
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth 2026-01-15 12:00
WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic 2026-01-13 11:07
1 2 3 4 5 11